Anticardiolipin IgG antibodies, quantitative, ICL
The test quantitatively determines IgG anticardiolipin antibodies, which are antiphospholipid syndrome (APS) markers. These antibodies increase thrombosis and pregnancy complication risk and may accompany systemic autoimmune diseases such as SLE.
Biomaterial: Venous blood
- Draw blood fasting (8-12 hours without food)
- Do not drink water
- Exclude alcohol 24 hours before
- Avoid stress and physical activity 30 minutes before
- If taking anticoagulants, immunomodulators, or hormonal drugs — inform physician.
- Suspected antiphospholipid syndrome;
- unexplained venous or arterial thromboses;
- recurrent miscarriages or pregnancy complications;
- systemic autoimmune diseases;
- disease activity and therapy efficacy monitoring.
Negative result — IgG anticardiolipin antibodies not detected; APS risk low.
Positive result — IgG anticardiolipin antibodies detected; characteristic of primary or secondary APS.
Important: results evaluated only together with clinical manifestations and other laboratory parameters.
